Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

BBNXDXCM

Area by area

Overall Quant Score

How does it look overall? (out of 100)

BBNX

62/100

DXCM

70/100

Quality

Is it a profitable, well-run business?

BBNX

2.0/10

DXCM

8.1/10

Growth

Is the company growing?

BBNX

7.3/10

DXCM

6.4/10

Valuation

Is the price reasonable? (higher = cheaper)

BBNX

0.0/10

DXCM

5.8/10

Risk

How risky are the shares? (higher = lower risk)

BBNX

2.2/10

DXCM

6.1/10

Momentum

Is the share price trending up?

BBNX

9.3/10

DXCM

8.2/10

Financial strength

Is the balance sheet healthy?

BBNX

7.5/10

DXCM

8.6/10

The balanced view

Model-generated

Beta Bionics, Inc.

This company scores above average, with a positive price trend and a healthy balance sheet, although its current valuation deserves attention.

Leads on: growth, momentum

Best feature: positive price trend (Trend alignment (50/200 SMA): 3/3)

Watch out: valuation may be demanding (P/E (TTM): -11.4x)

DexCom, Inc.

This company scores above average, with a healthy balance sheet and a positive price trend.

Leads on: quality, valuation, risk, financial strength

Best feature: healthy balance sheet (Piotroski F-Score: 8/9)

Watch out: weakest area: valuation (DCF upside: -52.4%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.